Compare CTBI & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTBI | PGEN |
|---|---|---|
| Founded | 1903 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 1995 | 2013 |
| Metric | CTBI | PGEN |
|---|---|---|
| Price | $65.57 | $4.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $63.00 | $8.33 |
| AVG Volume (30 Days) | 62.2K | ★ 3.6M |
| Earning Date | 04-15-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | ★ 17.79 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | N/A | ★ $230,981,000.00 |
| Revenue This Year | $14.02 | $1,115.92 |
| Revenue Next Year | $4.30 | $81.04 |
| P/E Ratio | $44.51 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $50.25 | $1.28 |
| 52 Week High | $68.50 | $5.47 |
| Indicator | CTBI | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 50.25 |
| Support Level | $64.00 | $3.96 |
| Resistance Level | $67.71 | $4.40 |
| Average True Range (ATR) | 1.32 | 0.27 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 40.50 | 29.89 |
Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and south-central Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services. The company operates in one reportable segment: community banking services.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.